Adherence to international follow-up guidelines in type 2 diabetes: A longitudinal cohort study in Luxembourg

PLoS ONE

Volumn 8, Issue 11, 2013, Pages

  Renard, Laurence M ^a,b   Bocquet, Valery ^a   Vidal Trecan, Gwenaelle ^b,c   Lair, Marie Lise ^a   Blum Boisgard, Claudine ^b  

^a Public Research Centre for Health   (Luxembourg)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOGLOBIN A1C; INSULIN; LIPID; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; COHORT ANALYSIS; CONSULTATION; ELECTROCARDIOGRAPHY; ETHNICITY; FEMALE; FOLLOW UP; HUMAN; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; LUXEMBOURG; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MIDDLE AGED; MOUTH EXAMINATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT ATTITUDE; PRACTICE GUIDELINE; PROTOCOL COMPLIANCE; SEX DIFFERENCE; UROLOGIC EXAMINATION; VISUAL SYSTEM EXAMINATION;

AGED; DIABETES MELLITUS, TYPE 2; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; GUIDELINE ADHERENCE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; KIDNEY FUNCTION TESTS; LIPOPROTEINS; LUXEMBOURG; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PRACTICE GUIDELINES AS TOPIC; PROPORTIONAL HAZARDS MODELS;

EID: 84893178169     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0080162     Document Type: Article

References (62)

1. Simon D, Fagot-Campagna A, Eschwege E, Balkau B (2009) Diabète: définition, dépistage et épidémiologie. Traité de diabétologie. Paris. pp. 3221.
2. Wild S, Roglic G, Green A, Sicree R, King H (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 104721053.
3. World Health Organization (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia. Geneva: WHO. 46 p.
4. Louazel V, Perquin M, Couffi gnal S, Rott C, Michel G, et al. (2008) Le diabète au Luxembourg: état de la situation à partir de données médico-administratives. Enjeux Santé. Available: http://www.crp-sante.lu/Research-Departments/Public-Health/Centre-for-Health- Studies#enjeux. Accessed 8 October 2013.
5. Renard LM, Bocquet V, Vidal-Trecan G, Lair ML, Couffignal S, et al. (2011) An algorithm to identify patients with treated type 2 diabetes using medico-administrative data. BMC Med Inform Decis Mak 11: 23.
6. Levin A (2008) Practice guidelines do improve patient outcomes: association or causation? Blood Purif 26: 67272.
7. Bovier PA, Sebo P, Abetel G, George F, Stalder H (2007) Adherence to recommended standards of diabetes care by Swiss primary care physicians. Swiss Med Wkly 137: 1732181.
8. Oh SW, Lee HJ, Chin HJ, Hwang JI (2011) Adherence to clinical practice guidelines and outcomes in diabetic patients. International journal for quality in health care : journal of the International Society for Quality in Health Care/ISQua 23: 4132419.
9. Sloan FA, Bethel MA, Lee PP, Brown DS, Feinglos MN (2004) Adherence to guidelines and its effects on hospitalizations with complications of type 2 diabetes. The review of diabetic studies : RDS 1: 29238.
10. Flanders WD, Presley R, McClellan WM (2005) Predictors of improved HbA1c testing by primary care physicians. Journal of health care for the poor and underserved 16: 7202733.
11. Ohman-Strickland PA, Orzano AJ, Hudson SV, Solberg LI, DiCiccio-Bloom B, et al. (2008) Quality of diabetes care in family medicine practices: influence of nurse-practitioners and physician's assistants. Annals of family medicine 6: 14222.
12. Rhee MK, Slocum W, Ziemer DC, Culler SD, Cook CB, et al. (2005) Patient adherence improves glycemic control. The Diabetes educator 31: 2402250.
13. Gross R, Tabenkin H, Porath A, Heymann A, Greenstein M, et al. (2003) The relationship between primary care physicians' adherence to guidelines for the treatment of diabetes and patient satisfaction: findings from a pilot study. Family practice 20: 5632569.
14. Marissal JP, Sailly JC, Crainich D, Lebrun T (2005) [Assessment of the budgetary impact of treatment guidelines in type II diabetes mellitus in France]. Rev Epidemiol Sante Publique 53 Spec No 1: 1S67278.
15. Stone MA, Wilkinson JC, Charpentier G, Clochard N, Grassi G, et al. (2010) Evaluation and comparison of guidelines for the management of people with type 2 diabetes from eight European countries. Diabetes Res Clin Pract 87: 2522260.
16. Beckles GL, Engelgau MM, Narayan KM, Herman WH, Aubert RE, et al. (1998) Population-based assessment of the level of care among adults with diabetes in the U.S. Diabetes care 21: 143221438.
17. Ratsep A, Oja I, Kalda R, Lember M (2007) Family doctors' assessment of patient- and health care system-related factors contributing to non-adherence to diabetes mellitus guidelines. Primary care diabetes 1: 93297.
18. Sohn C (2006) Villes et agglomérations au Grand-Duché de Luxembourg. Proposition d'une nomenclature des unités urbaines. Luxembourg. 1216 p.
19. WHO Collaborating Centre for Drug Statistics Methodology (2011) ATC/DDD Index 2011.
20. Renard L, Bocquet V, Vidal-Trecan G, Lair M-L, Couffignal S, et al. An algorithm to identify patients with treated type 2 diabetes using medico-administrative data. BMC Medical Informatics and Decision Making. Available: Accessed
21. American Diabetes Association (2003) Standards of medical care for patients with diabetes mellitus. Diabetes Care 26 Suppl 1: S33250.
22. American Diabetes Association (2007) Standards of medical care in diabetes-2007. Diabetes Care 30 Suppl 1: S42S41.
23. AFSSAPS HAS (2007) Traitement médicamenteux du diabète de type 2 (actualisation): Recommandations. Diabetes & Metabolism 32.
24. German Diabetes Association, German Geriatric Society (2006) Evidence-based Guideline: Diagnosis,Treatment and Follow-up of Diabetes mellitus in the Elderly. 52 p.
25. Haute Autorité de Santé (2007) La prise en charge de votre maladie, le diabète de type 2. 5 p.
26. Wens J, Sunaert P, Nobels F, Feyen L, Van Crombruggen P, et al. (2007) Recommandations de Bonne Pratique: Diabete sucré de type 2. Societé Scientifique de Médecine Générale. 72 p.
27. Haute Autorité de Santé (2007) Guide - Affection de longue durée - Diabète de type 2. 23 p.
28. International Diabetes Federation (2005) Global Guideline for Type 2 Diabetes. 118 p.
29. Cohen J (1988) Statistical power analysis for the behaviorial sciences: Routledge.
30. Peterson B, Harrell FE, Jr (1990) Partial Proportional Odds Models for Ordinal Response Variables. Applied Statistics 39: 2052217.
31. Allison P (2001) Missing Data: Sage Publications.
32. Schafer JL (1997) Analysis of Incomplete Multivariate Data; Hall C, editor. London.
33. Meng X (1992) Performing Likelihood Ratio Tests with Multiply-Imputed Data Sets. Biometrika 79: 1032111.
34. Rubin D (1987) Multiple Imputation for Nonresponse in Surveys; Sons JW, editor. New York: Wiley-Interscience.
35. Robert J, Roudier C, Poutignat N, Fagot-Campagna A, Weill A, et al. (2009) Health care of persons with type 2 diabetes in France in 2007 and trends compared to 2001. Bulletin Epidemiologique Hebdomadaire 4552460.
36. Yamashita T, Kart CS, Noe DA (2011) Predictors of adherence with self-care guidelines among persons with type 2 diabetes: results from a logistic regression tree analysis. Journal of behavioral medicine.
37. Kramer HU, Ruter G, Schottker B, Rothenbacher D, Rosemann T, et al. (2012) Gender differences in healthcare utilization of patients with diabetes. The American journal of managed care 18: 3622369.
38. Institut national de la statistique et des études économiques (2010) Le Luxembourg en chiffres 2010. Luxembourg: Statec.
39. Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J (1999) Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ 318: 5272530.
40. Juul L, Maindal HT, Frydenberg M, Kristensen JK, Sandbaek A (2012) Quality of type 2 diabetes management in general practice is associated with involvement of general practice nurses. Primary care diabetes 6: 2212228.
41. American Diabetes Association (2010) Diabetes Care. Introduction. Diabetes Care 33 Suppl 1: S122.
42. AFSSAPS HAS (2006) Traitement médicamenteux du diabète de type 2 (actualisation): Recommandations.
43. Kirkman MS, Williams SR, Caffrey HH, Marrero DG (2002) Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes care 25: 194621951.
44. Renard LM, Bocquet V, Lair M-L (2013) Rapport National Diabète: Bilan épidémiologique, Prise en charge, Représentations. 200022010. Luxembourg: CRP-Santé. 150 p.
45. Javitt JC, Aiello LP (1996) Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med 124: 1642169.
46. Conseil Scientifique. Conseil Scientifique Domaine de la Santé. Available: http://www.conseil-scientifique.lu/. Accessed 18 July 2013.
47. Conseil Scientifique. Publications-Obésité. Available: http://www.conseilscientifique.lu/index.php?id =100. Accessed 8 October 2013.
48. Drabik A, Graf C, Buscher G, Stock S (2012) [Evaluating the effectiveness of a disease management program diabetes in the German Statutory Health Insurance: first results and methodological considerations]. Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen 106: 6492655.
49. Stark RG, Schunk MV, Meisinger C, Rathmann W, Leidl R, et al. (2011) Medical care of type 2 diabetes in German disease management programmes: a population-based evaluation. Diabetes/metabolism research and reviews 27: 3832391.
50. Rothe U, Muller G, Schwarz PE, Seifert M, Kunath H, et al. (2008) Evaluation of a diabetes management system based on practice guidelines, integrated care, and continuous quality management in a Federal State of Germany: a population-based approach to health care research. Diabetes care 31: 8632868.
51. Steuten LM, Vrijhoef HJ, Landewe-Cleuren S, Schaper N, Van Merode GG, et al. (2007) A disease management programme for patients with diabetes mellitus is associated with improved quality of care within existing budgets. Diabetic medicine : a journal of the British Diabetic Association 24: 111221120.
52. Flamm M, Panisch S, Winkler H, Sonnichsen AC (2012) Impact of a randomized control group on perceived effectiveness of a Disease Management Programme for diabetes type 2. European journal of public health 22: 6252629.
53. Sonnichsen AC, Winkler H, Flamm M, Panisch S, Kowatsch P, et al. (2010) The effectiveness of the Austrian disease management programme for type 2 diabetes: a cluster-randomised controlled trial. BMC family practice 11: 86.
54. Flamm M, Panisch S, Winkler H, Johansson T, Weitgasser R, et al. (2012) Effectiveness of the Austrian disease management programme "Therapie Aktiv" for type 2 diabetes regarding the improvement of metabolic control, risk profile and guideline adherence: 2 years of follow up. Wiener klinische Wochenschrift 124: 6392646.
55. Ostermann H, Hoess V, Mueller M (2012) Efficiency of the Austrian disease management program for diabetes mellitus type 2: a historic cohort study based on health insurance provider's routine data. BMC public health 12: 490.
56. Gravely S, Reid RD, Oh P, Ross H, Stewart DE, et al. (2012) A prospective examination of disease management program use by complex cardiac outpatients. The Canadian journal of cardiology 28: 4902496.
57. Linder R, Ahrens S, Koppel D, Heilmann T, Verheyen F (2011) The benefit and efficiency of the disease management program for type 2 diabetes. Deutsches Arzteblatt international 108: 1552162.
58. Kanavos P, Van den Aardweg S, Schurer W (2012) Diabetes expenditure, burden of disease and management in 5 EU countries. London. 113 p.
59. Austin S, Wolfe BL (2011) The effect of patient reminders and gas station gift cards on patient adherence to testing guidelines for diabetes. WMJ : official publication of the State Medical Society of Wisconsin 110: 1322137.
60. Scott A, Schurer S, Jensen PH, Sivey P (2009) The effects of an incentive program on quality of care in diabetes management. Health economics 18: 109121108.
61. Lippi Bruni M, Nobilio L, Ugolini C (2009) Economic incentives in general practice: the impact of pay-for-participation and pay-for-compliance programs on diabetes care. Health policy (Amsterdam, Netherlands) 90: 1402148.
62. Tchicaya A, Lorentz N (2011) Working Paper N u2011-19: Inégalités sociales dans le renoncement aux soins de santé et dans leur utilisation. Differdange: CEPS/instead. 49 p.